Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting
在瑞典,针对肌层浸润性膀胱癌患者,根据分子亚型降低新辅助化疗强度的成本效益分析
期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1556881
Saha, Sanjib; Gerdtham, Ulf-Göran; Sjödahl, Gottfrid; Häggström, Christel; Catto, James W F; Kelly, John D; Ullén, Anders; Holmberg, Lars; Liedberg, Fredrik